Showing results (571-580 of 715) with videos related to

Sort By:
Pageof 72
Cancer Research|January 7, 2014
The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progressionAdam M Sonabend, Mukesh Bansal, Paolo Guarnieri, et al.
Nature Communications|September 2, 2021
Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastomaTrang T T Nguyen, Enyuan Shang, Chang Shu, et al.
Arthritis and Rheumatism|September 30, 2006
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activityChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus ErythematosusJie An, Tracy A Briggs, Audrey Dumax-Vorzet, et al.
Journal of Neuro-Oncology|December 22, 2017
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastomaDeborah R Smith, Cheng-Chia Wu, Heva J Saadatmand, et al.
Neurosurgery|October 7, 2015
Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 PatientsTony J C Wang, Ashish Jani, Juan P Estrada, et al.
Rheumatology (Oxford, England)|December 8, 2020
BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: baseline multi-centre audit in the UKFiona A Pearce, Megan Rutter, Ravinder Sandhu, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosisAngeliki Mela, Abby Brand, Aayushi Mahajan, et al.
Journal of Neuro-Oncology|August 14, 2019
Extent of resection and survival for oligodendroglioma: a U.S. population-based studyConnor J Kinslow, Andrew L A Garton, Ali I Rae, et al.
Neuro-Oncology|April 26, 2015
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?Tony J C Wang, Shumaila Saad, Yasir H Qureshi, et al.
Pageof 72